Mick Sehgal
A multifaceted executive with both domestic and global experience, Mick Sehgal has
a proven track record in profit and loss management, information technology project
management, operations assessment, risk analysis, business process reengineering,
business case analysis, mergers/acquisitions and strategic planning. Mick has more
than 20 years’ experience, starting at AT&T, where over a seven-year career
he held positions as operations manager, senior Auditor and senior consultant. Before
joining Sequent, he was CFO and a member of the board of directors at Hamilton Scientific,
an e-health company. Mick has also been the CEO of Frontier Metals, a multinational
metal trading company. At Sequent, Mick has delivered more than 50 IT projects in
five years to mid-capital and Fortune 500 companies. Projects range from business
intelligence management dashboards to enterprise resource planning (ERP) implementations.
He is a frequent speaker on business intelligence (BI) and data warehousing at such
forums as New Jersey Technology Council and the New Jersey Institute of Technology.
He has an M.S. in applied statistics and an M.B.A. in finance from the University
of North Carolina. His B.S. is in mechanical engineering from MSU, one of India’s
major universities.
CJ Singh
CJ is a seasoned technology professional with extensive business experience and
development focused on end users. He has led teams on numerous cross-functional
projects in a broad range of industries, including total lifecycle software development;
system architecture, design and development; and. data integration projects using
the latest software development tools and techniques. His superior command of numerous
front- and back-end languages makes him an exceptional leader for any technology
business solution project. CJ was a technical manager and team leader for Omnipoint,
a pioneer and leading provider of GSM-based mobile phone services. The company has
since merged with Voicestream Wireless and T-Mobile. At Sequent, CJ has been lead
solution designer system integrator for numerous clients, including Novartis, Englert,
Inc., New Jersey Sports Authority-Meadowlands Racetrack; Voicestream Wireless; Easylink
Services, Expo Electronics and 6th Avenue Electronics. CJ has an M.B.A. with a focus
on information technology from Rutgers Business School. He graduated summa cum laude
from the New Jersey Institute of Technology.
Steven Harwood
Originally from New York, Steven Harwood holds a BA degree in Latin American Studies
from the Univ. of Albany and an MBA in International Business from the State Univ.
of New York at Binghamton. Mr. Harwood entered the pharmaceutical field in the early
80’s with Ayerst/Wyeth where he served as Promotion Manager -International
and Regional Manager — Asia/Pacific. He then spent 3 years based in India
with Farmitalia Carlo Erba (ultimately acquired by Pfizer) where he set up a new
pharmaceutical operation, and 2 years in Taiwan as General Manager for Sanofi (Sanofi-Aventis).
After a 5-year stint as an independent consultant, which included lecturing on International
Business at SUNY Binghamton’s MBA program, Mr. Harwood was hired as Regional
Director-Latin America for Nycomed/Amersham, a company subsequently acquired by
GE Healthcare. Following 5 years with GE Healthcare, at the end of 2008 Mr. Harwood
created Latin Nexus, LLC based in Miami, Florida to promote health care initiatives
between Latin America and other global markets. Mr. Harwood is proficient in 7 languages
including English, Spanish, Portuguese, French, Italian, Mandarin Chinese and Hindi.
Holger Meissner
Holger Meissner is the founder and owner of Adler Life Sciences, LLC a boutique
business and competitive intelligence firm for the Life Science Industry located
in New Jersey. Adler’s business mission is to help its clients make timelier,
more informed and smarter business decisions that help their companies “win”
in an intensely competitive business environment. Prior to founding Adler Life Sciences
in 2007, Holger was the Head of the Global Competitive Intelligence at Bayer HealthCare
Consumer Care Division in Morristown, New Jersey. He joined the Bayer Group in 1985.
Throughout his years at Bayer, he held positions of increasing responsibility in
local, regional and global marketing functions for the Consumer Care Division, managing
brands such as Bayer Aspirin, Alka-Seltzer, and Canesten. During this time he worked
in various countries such as Germany, Colombia, South Korea, Japan, Singapore, Hong
Kong and China.
John J. Trombetta
Overview
Over thirty years of diverse experience in the pharmaceutical industry, including
quality assurance, long range forecasting, business and strategic planning, corporate
and business development (including numerous product and company licensing and acquisition
opportunity evaluations), marketing research, and marketing management.
Education and Experience
Mr. Trombetta has over thirty years of diverse experience in the pharmaceutical
industry, including quality assurance, long range forecasting, business and strategic
planning, corporate and business development (including numerous product and company
licensing and acquisition opportunity evaluations), marketing research, and marketing
management.
After graduation from LaSalle College with a BA in Chemistry, he received his MBA
from Widener University in 1972 and a year later joined Stuart Pharmaceuticals (now
AstraZeneca Pharmaceuticals) in Quality Assurance. In this position he developed
and implemented a control chart program; a computerized storage and retrieval system
for product release data; a vendor assurance program; a product complaint classification
and reporting system and a product complaint tracking system.
In 1983 Mr. Trombetta joined Berlex Laboratories as Manager, Business Development
& Strategic Planning where he assisted the Executive Committee in establishing corporate
objectives and in developing a medium range business plan. In 1984, Mr. Trombetta
was selected to assume the position of Manager, Marketing Research Pharmaceuticals
and to build a team that would provide a balanced program of primary and secondary
market research for the pharmaceutical market area.
In 1996 as Director, Corporate Development, Mr. Trombetta assisted the CEO and the
Executive Committee in the management of Berlex’s strategic corporate alliances
From 1997 through 1999, Mr. Trombetta was Director of Business Development and Market
Research for the Female Healthcare strategic unit of Berlex Laboratories
Most recently, Mr. Trombetta was a Senior Vice President of Thomson Physicians World
and was responsible for managing and directing the operations of a market research
division (Thomson Advanced Health Market Research)
In 2003, Mr. Trombetta started his own consulting firm, TRA, LLC. Mr. Trombetta
provides consulting services to the healthcare, pharmaceutical, and diagnostic imaging
industries utilizing his over thirty years of extensive marketing and market research
experience.
Bill Sammon
Bill Sammon is a principal at Decision Intelligence Inc. (DII), an independent strategy
and research consulting firm he founded in 2009 located in Cold Spring, NY. DII
collaborates with consulting firms on corporate, business unit, and product line
projects designed to assist clients in developing strategic, business development,
marketing, R&D, manufacturing, and investor relations decisions.
Bill began working in the pharmaceutical industry when he joined Pfizer Inc’s
Corporate Strategic Planning Department in 1982 as a senior analyst. Prior to that,
he served 11 years in U.S. Army intelligence assignments (1968-1979) and spent three
years at International Paper in strategic planning where he founded that corporation’s
competitive intelligence department. From 1987 to 1990, he worked at two Wall Street
brokerage firms (Mabon Nugent and Wood Gundy) as a sell-side pharmaceutical industry
analyst. In 1990, he returned to Pfizer as Director Planning, US pharmaceutical
operations.
In May 2008, Bill retired from Pfizer after 23 years of service in various strategic
planning, business development and investor relations senior staff positions. In
his last position, he served as Senior Director, Strategic Information and Analysis,
Investor Development, Corporate Finance. His principal responsibilities included:
1) supervising strategic intelligence studies assessing competitive threats and
strategic opportunities, 2) providing strategic intelligence to senior corporate
executives, 3) providing intelligence on competitor institutional investors and
competitors’ investor relations strategies, and 4) leading Pfizer’s
Corporate Business Intelligence Advisory Group which led product marketing teams
and business units in the development and management of internal and external business
and competitive intelligence assets.
Bill is the editor and author of Business Competitor Intelligence, (John Wiley &
Sons, 1984) and contributed a chapter on strategic business intelligence to the
Handbook of Strategic Planning, (John Wiley & Sons, 1986). He earned a BA in political
science from Boston College (1964), an MA in political science from the University
of Chicago (1975), and an MA in finance from Long Island University (1979). Bill
is a graduate of the U.S. Army’s Military Intelligence Schools and the Command
and General Staff College (1987). He retired from the U.S. Army Reserve in 1996
as a Lieutenant Colonel after 28 years of service.
Mark L. Horn MD, MPH
Mark L. Horn MD, MPH is a Board Certified Internist and Rheumatologist with over
twenty years of experience in the large Pharmaceutical Industry. In 2008 he founded
MedaConsults LLC, a Health Policy, Medical & Scientific Consulting Firm based in
New Jersey. He currently serves as a Principal Consultant in that Firm, as the Chief
Medical Officer of Target Health, Inc. a Clinical Research Organization based in
New York City and as a Senior Advisor to Avalere Health, a health policy consulting
firm based in Washington, DC.
During a 25 year career at Pfizer, Dr. Horn managed development programs in multiple
clinical disciplines, among them arthritis & inflammation and cardiovascular diseases,
including hypertension and angina. In addition, during his tenure at Pfizer he led
teams in Licensing & Development, Medical Marketing in multiple therapeutic areas,
and Worldwide Public Affairs and Policy.
Dr. Horn retired from Pfizer Inc following several years’ leadership of the
Worldwide Medical Policy and Evidence Based Medicine/Health Technology Assessment
Teams. These groups were responsible for crafting strategies to address the increasingly
complex, often cost driven, globally diverse requirements for clinical and economic
data to support reimbursement of prescription medicines by public and private payers.
The groups were also responsible for both portfolio and product strategies responsive
to the array of health reform initiatives, among them insurance reform & benefit
design, pay for performance, quality initiatives (including physician economic rankings),
and (CMS driven) coverage with evidence development programs, anticipated in the
United States.
In addition to his MD (New York University) and undergraduate (Brown) degrees, Dr.
Horn holds an MPH degree in Health Policy and Management (Columbia).
Dr. Horn serves on the voluntary clinical faculty of the Mount Sinai Hospital and
School of Medicine in New York City, is a current member of the US Pharmacopoeia
Safe Medication Use Expert Committee and served on the US Pharmacopoeia Medicare
Model Guidelines Expert Committee. He served for over a decade on the American Medical
Association Continuing Medical Education Task Force on Provider/Industry/Academic
Collaboration. He is a member of the American Medical Association and a Fellow of
the American College of Rheumatology and is Board Certified in Internal Medicine
and Rheumatology.
During 2009 Dr. Horn has addressed the State Senate Presidents’ Forum, the
Western Pain Society Annual Meeting and the National Pain Week meeting on the implications
of Health System Reform for patient care. He recently delivered the Keynote Address
at the New Jersey Technology Council Forum e-Summit examining the role of Electronic
Health Records in clinical care.
Thomas Prendergast, MD
Dr. Prendergast is an actively practicing Cardiothoracic Surgeon in New Brunswick,
New Jersey, USA. His responsibilities include clinical and research activities,
as well as electronic medical recording (EMR).
Dr. Prendergast received a BS degree in Biophysics and a BS in Psychology from Pennsylvania
State University. He also received his MD degree from Penn State, Hershey Campus.
His general surgery training included five years at University of Massachusetts
Medical School and Cardiothoracic Surgery training at LA County/University of Southern
California Medical School. Subsequent fellowship training in Pediatric Cardiothoracic
Surgery was at Children's Hospital Los Angeles along with Heart and Lung Transplantation
fellowships at both University of Southern California and Temple University Hospital
in Philadelphia. He spent three years at University of Kansas Medical School as
Director of Congenital Cardiothoracic Surgery and responsibilities included reestablishing
heart and lung transplant programs. After two more years at Temple University Hospital,
he joined up with Newark Beth Israel/St. Barnabas Hospital in New Jersey, where
he eventually assumed responsibility for the Heart Transplant directorship. He is
presently at Robert Wood Johnson University Hospital (RWJUH) as part of the University
of Medicine and Dentistry of New Jersey (UMDNJ), where he is a busy cardiac surgery
practitioner performing 200-250 open heart operations per year. He is presently
the Surgical Director of Cardiac Transplantation and Ventricular Assistance at RWJUH
and holds an Associate Professor of Surgery position at the UMDNJ.
In addition to being an active participant in stem cell research program development,
he has spent a great deal of time in EMR development. Business interests include
medical research funding, real estate development and humanitarian development for
American Veterans. He presently resides in Berkeley Heights, New Jersey with his
wife and daughter.
Dr. Frederic J. Vagnini
Dr. Frederic J. Vagnini is one of the most unique physicians and health educators
in the world. After graduation from St. Louis University School of Medicine in 1963,
Dr. Vagnini underwent 8 years of post doctorate internship and residency. These
years studying surgery, vascular, heart and lung surgery were spent at the Downstate
Medical Center, Brooklyn, New York and Columbia Presbyterian Medical Center, New
York. Following completion of training Dr. Vagnini served in the United States Army
as a Lieutenant Colonel and subsequently entered into private practice on Long Island,
New York. For the next 25 years Dr. Vagnini practiced as a heart, lung and blood
vessel surgeon. He has operated on thousands of patients with heart and blood vessel
disease. As his career continued Dr. Vagnini became interested in Health Education,
Preventive Medicine and Clinical Nutrition. Because of his vast experience in the
area of heart disease and nutrition he became a frequent guest speaker and has appeared
numerous times on local and national radio and television.
Dr. Vagnini has extensive media experience with hundreds of radio and television
appearances. He presently hosts a live call in show on WOR 710 AM. The show is called
"The Heart Show" and airs from 4-5 PM Sundays. Dr. Vagnini formerly hosted a national
health show on Fox Television.